🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Next issue of #CardioNews 10.05.2024 Focus on #lipid management, #CardioCT, heart and pregnancy, sleep apnoe and #obesity and #heartfailure, lots of studies, discussions and more. Thanks to #MeinradGawaz, Deutsche Gesellschaft für Kardiologie, Springer Medizin and all authors for hard work Just #Heartwork:)

🔺There is no high-quality evidence to support use of #BetaBlockers in #HFpEF ncbi.nlm.nih.gov/pmc/articles/P… 🔺In absence of other indications, consider withdrawing BBs from HFpEF regimen, especially in setting of #chronotropic incompetence (ie chronotropic index <0.62 during max #CPET)

🔥Important data from the European Society of Cardiology EORP worldwide Registry on #PPCM‼️ @Karen.Sliwa1 Mark Petrie Amina Alexandra Frogoudaki Alexandre Mebazaa EHJ Editor-in-Chief Shelley Zieroth Rudolf de Boer David Duncker Giuseppe Galati Tienush Rassaf Tobias Pfeffer Philipp Breitbart Hannah Billig BiykemBozkurt #HFA

LBCT 1 at #heartfailure2024 🔥Simultaneous publication in #EHJ: ✅ The consistency of benefit of remote hemodynamic monitoring in chronic #heartfailure - a predefined subgroup analysis of MONITOR-HF. Rudolf de Boer ⁦Shelley Zieroth⁩ ⁦EHJ Editor-in-Chief⁩ academic.oup.com/eurheartj/adva…

Secondary analysis of the PRE18FFIR study showed individual coronary atherosclerotic plaque activity is associated with subsequent myocardial infarction in the same coronary artery territory, which cascades into patient-level risk bit.ly/45fT9Jf #JACC #cvMI #cvPET

🔥hot of the press: Great Debate: #SGLT2 inhibitors should be first-line treatment in #HFrEF ✅ academic.oup.com/eurheartj/arti… EHJ Editor-in-Chief Rudolf de Boer Shelley Zieroth David Duncker Samira Soltani Young DGK @MHH_life Giuseppe Galati Philipp Breitbart Hannah Billig Daniel Messiha, MD Tienush Rassaf

HFAPresident Holger Thiele MHH HTTG-Chirurgie Arjang Ruhparwar Deutsche Gesellschaft für Kardiologie Robert Mentz, MD Javed Butler Steve Greene Tobias Pfeffer Peter Lüdike Tobias Koenig MD Henrike Hillmann EJHF Editor-in-Chief European Society of Cardiology European Society of Cardiology News Ale𝕏ander Weymann

ICYMI: #EchoFirst outcomes from #MTEER #CLASPIID randomized trial for degenerative #vhdMR: #PASCAL system use & smaller flail gaps ➡️ more likely to have mild or less MR at 6 months. bit.ly/3JTxU5Z #JACCIMG RTHahnMD Daniel Kalbacher Tobias Ruf Sasan Ryan Raissi, MD

Wir trauern um unseren Kollegen – um andere zu schützen hat er sein Leben gegeben! Am Freitag wurde unser Kollege vom PP Mannheim durch einen Messerangriff schwer verletzt und ist heute seinen Verletzungen erlegen. PM des LKA: presseportal.de/blaulicht/pm/1… #einervonuns #mannheim

Patients will soon be able to bring their phone into your office and say, "Hey doctor, my phone says I have heart failure...what does this mean?" More technology disrupting the status quo in identifying, diagnosing, and treating patients with heart failure. Lets go.

💥🔥off-the-press!!! CONGRATULATIONS @MGercek40 & Volker Rudolph on this important and sophisticated Study!!! It was a pleasure&honor to support this 🤝!!! #TEER Young DGK Deutsche Gesellschaft für Kardiologie AGIK

Why do HF patients often have low BP and orthostasis? And what does it mean for clinical practice? See great new study in Journal of Cardiac Failure and editorial for context below. sciencedirect.com/science/articl…

Tailoring PEEP through real-time RV #PVLoop #Hemodynamics in VA-ECMO patients "This unique approach of tailoring mech ventilation via cardio-respiratory physiology through in-vivo RV #PVloops may provide a novel way to optimize patient outcomes." Link: lnkd.in/gQ5bq8h6

🚨🚨🚨 MAJOR news in the #amyloidosis world this morning with positive topline results of #HELIOS-B. #Vutrisiran met all primary & secondary endpoints. Let's break down what we know... #StanfordAmyloidCenter (1/13)

Excellent results with #TEER + OMT vs OMT in patients with severe SMR. The end of a debate? #ESCCongress2024 PCRonline 🫀

RESHAPE-HF2 shows no impact on mortality but significant reduction in HFH and improvement in KCCQ. All call for a larger trial to confirm MTEER for lower risk and lower MR severity. #ESC2024

mTEER is non inferior to Surgery in #SMR patients with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device at 1 year. MATTERHORN trail #ESCCongress2024 PCRonline 🫀 nejm.org/doi/full/10.10…

#HFpEF mit ⬆️ Prävalenz & schlechter Prognose 👉 frühzeitig an kardiale Amyloidose denken 👉 besonderer Wert der MR-Antagonisten & SGLT2i bei kardialer Amyloidose aufgrund guter Toleranz 👉 Anbindung an Zentrum #DGKHerztage #Herzinsuffizienz Deutsche Gesellschaft für Kardiologie Young DGK Herzmedizin.de

#DGKHerztage nicht verpassen am Freitag 9.45 ✅ ➡️ #HIGHLIGHT Session mit 3️⃣ #Herzinsuffizienz Studien‼️ Daniel Messiha, MD Djawid Hashemi Maria Papathanasiou Philipp Breitbart Hannah Billig David Duncker Deutsche Gesellschaft für Kardiologie Young DGK AGEP Samira Soltani Tienush Rassaf Peter Lüdike @MHH_life